Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Gastroenterology
.
2017 May;152(6):1629-1630.
doi: 10.1053/j.gastro.2016.09.068.
Epub 2017 Apr 1.
Authors
Cong Dai
1
,
Min Jiang
1
,
Ming-Jun Sun
1
Affiliation
1
Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
PMID:
28376323
DOI:
10.1053/j.gastro.2016.09.068
No abstract available
Publication types
Letter
Comment
MeSH terms
Diarrhea
Humans
Irritable Bowel Syndrome*
Rifamycins*
Rifaximin
Substances
Rifamycins
Rifaximin